234 related articles for article (PubMed ID: 25939068)
1. Development of a novel antimicrobial screening system targeting the pyoverdine-mediated iron acquisition system and xenobiotic efflux pumps.
Sato K; Ushioda K; Akiba K; Matsumoto Y; Maseda H; Ando T; Isogai E; Nakae T; Yoneyama H
Molecules; 2015 Apr; 20(5):7790-806. PubMed ID: 25939068
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
[TBL] [Abstract][Full Text] [Related]
3. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
4. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
[TBL] [Abstract][Full Text] [Related]
5. Mutations in NalC induce MexAB-OprM overexpression resulting in high level of aztreonam resistance in environmental isolates of Pseudomonas aeruginosa.
Braz VS; Furlan JP; Fernandes AF; Stehling EG
FEMS Microbiol Lett; 2016 Aug; 363(16):. PubMed ID: 27412168
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
[TBL] [Abstract][Full Text] [Related]
7. Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
Sugimura M; Maseda H; Hanaki H; Nakae T
Antimicrob Agents Chemother; 2008 Nov; 52(11):4141-4. PubMed ID: 18676884
[TBL] [Abstract][Full Text] [Related]
8. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
[TBL] [Abstract][Full Text] [Related]
9. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
Dean CR; Visalli MA; Projan SJ; Sum PE; Bradford PA
Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
[TBL] [Abstract][Full Text] [Related]
10. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
[TBL] [Abstract][Full Text] [Related]
11. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS
J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
Adamson DH; Krikstopaityte V; Coote PJ
J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; MartÃnez JL
mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
[TBL] [Abstract][Full Text] [Related]
14. Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.
Middlemiss JK; Poole K
J Bacteriol; 2004 Mar; 186(5):1258-69. PubMed ID: 14973037
[TBL] [Abstract][Full Text] [Related]
15. Fuzheng Touxie Jiedu Huayu Decoction inhibits the MexAB-OprM efflux pump and quorum sensing-mediated biofilm formation in difficult-to-treat multidrug resistance Pseudomonas aeruginosa.
Liu T; Xu H; Huang T; Liu G; Cao H; Lin Y; Li Y; Li Y; Yao X
J Ethnopharmacol; 2024 Oct; 332():118365. PubMed ID: 38796070
[TBL] [Abstract][Full Text] [Related]
16. Tat pathway-mediated translocation of the sec pathway substrate protein MexA, an inner membrane component of the MexAB-OprM xenobiotic extrusion pump in Pseudomonas aeruginosa.
Yoneyama H; Akiba K; Hori H; Ando T; Nakae T
Antimicrob Agents Chemother; 2010 Apr; 54(4):1492-7. PubMed ID: 20100880
[TBL] [Abstract][Full Text] [Related]
17. Linkage of the efflux-pump expression level with substrate extrusion rate in the MexAB-OprM efflux pump of Pseudomonas aeruginosa.
Narita S; Eda S; Yoshihara E; Nakae T
Biochem Biophys Res Commun; 2003 Sep; 308(4):922-6. PubMed ID: 12927807
[TBL] [Abstract][Full Text] [Related]
18. The MexJK Multidrug Efflux Pump Is Not Involved in Acquired or Intrinsic Antibiotic Resistance in
Amieva R; Gil-Gil T; MartÃnez JL; Alcalde-Rico M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886841
[TBL] [Abstract][Full Text] [Related]
19. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719.
Cao L; Srikumar R; Poole K
Mol Microbiol; 2004 Sep; 53(5):1423-36. PubMed ID: 15387820
[TBL] [Abstract][Full Text] [Related]
20. Effect of piperine on the inhibitory potential of MexAB-OprM efflux pump and imipenem resistance in carbapenem-resistant Pseudomonas aeruginosa.
Liu Y; Zhu R; Liu X; Li D; Guo M; Fei B; Ren Y; You X; Li Y
Microb Pathog; 2023 Dec; 185():106397. PubMed ID: 37852553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
